Literature DB >> 15261426

The epidemiology of asbestos-related diseases.

Jacek Niklinski1, Wieslawa Niklinska, Elzbieta Chyczewska, Jerzy Laudanski, Wojciech Naumnik, Lech Chyczewski, Eric Pluygers.   

Abstract

Asbestos has been recognised as a potential health hazard since the 1940s. Of the two major species of asbestos; white asbestos (chrysotile) and blue asbestos (crocidolite), both of which are hazardous. The workers at extraction facilities are at the greatest risk of exposure to asbestos and, therefore, the development of asbestos-related diseases, commonly mesothelioma. However, other individuals at a high risk of exposure include asbestos-cement workers, insulation workers and ship-yard workers. Environmental exposure to asbestos can occur as a result of living in areas either characterised by natural outcrops of asbestos or asbestos-related materials, or those close to asbestos-producing or -using plants. Unfortunately, man-made fibre alternatives to asbestos, such as rock and slag-wool and glass wool, have also been shown to have a detrimental effect on human health. A characteristic of mesothelioma is that there is a long latency period (20-30 years) before the signs and symptoms of the disease become apparent. In addition, diagnosis of the disease can be difficult. The use of biological markers, such as tissue polypeptide antigen, may play a useful role in the early detection of the disease in individuals at risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261426     DOI: 10.1016/j.lungcan.2004.04.008

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  12 in total

1.  Asbestos activates CH12.LX B-lymphocytes via macrophage signaling.

Authors:  Devon L Rasmussen; Jean C Pfau
Journal:  J Immunotoxicol       Date:  2011-12-01       Impact factor: 3.000

2.  Immunological alterations found in mesothelioma patients and supporting experimental evidence.

Authors:  Yoshie Miura; Yasumitsu Nishimura; Megumi Maeda; Shuko Murakami; Hiroaki Hayashi; Kazuya Fukuoka; Takumi Kishimoto; Takashi Nakano; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

3.  An updated historical cohort mortality study of workers exposed to asbestos in a refitting shipyard, 1947-2007.

Authors:  Kimiko Tomioka; Yuji Natori; Shinji Kumagai; Norio Kurumatani
Journal:  Int Arch Occup Environ Health       Date:  2011-06-09       Impact factor: 3.015

4.  Occupational exposure to asbestos and man-made vitreous fibres and risk of lung cancer: a multicentre case-control study in Europe.

Authors:  Rafael Carel; Ann C Olsson; David Zaridze; Neonila Szeszenia-Dabrowska; Peter Rudnai; Jolanta Lissowska; Eleonora Fabianova; Adrian Cassidy; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Joelle Fevotte; Tony Fletcher; Andrea 't Mannetje; Paul Brennan; Paolo Boffetta
Journal:  Occup Environ Med       Date:  2006-10-19       Impact factor: 4.402

5.  Temporal trend, geographic distribution, and publication quality in asbestos research.

Authors:  Donatella Ugolini; Stefano Bonassi; Alfonso Cristaudo; Giacomo Leoncini; Giovanni Battista Ratto; Monica Neri
Journal:  Environ Sci Pollut Res Int       Date:  2014-12-06       Impact factor: 4.223

6.  Immunological changes in mesothelioma patients and their experimental detection.

Authors:  Megumi Maeda; Yoshie Miura; Yasumitsu Nishimura; Shuko Murakami; Hiroaki Hayashi; Naoko Kumagai; Tamayo Hatayama; Minako Katoh; Naomi Miyahara; Shoko Yamamoto; Kazuya Fukuoka; Takumi Kishimoto; Takashi Nakano; Takemi Otsuki
Journal:  Clin Med Circ Respirat Pulm Med       Date:  2008-03-26

Review 7.  Additive Synergism between Asbestos and Smoking in Lung Cancer Risk: A Systematic Review and Meta-Analysis.

Authors:  Yuwadee Ngamwong; Wimonchat Tangamornsuksan; Ornrat Lohitnavy; Nathorn Chaiyakunapruk; C Norman Scholfield; Brad Reisfeld; Manupat Lohitnavy
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

8.  Environmentally related diseases and the possibility of valuation of their social costs.

Authors:  Ilona Hajok; Ewa Marchwińska; Grzegorz Dziubanek; Bernadeta Kuraszewska; Agata Piekut
Journal:  ScientificWorldJournal       Date:  2014-10-14

9.  Pleural plaques in lung cancer screening by low-dose computed tomography: prevalence, association with lung cancer and mortality.

Authors:  Mario Silva; Nicola Sverzellati; Davide Colombi; Gianluca Milanese; Carlo La Vecchia; Carlotta Galeone; Alfonso Marchianò; Ugo Pastorino
Journal:  BMC Pulm Med       Date:  2017-11-25       Impact factor: 3.317

10.  Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma.

Authors:  Toshiyuki Satoh; Takeo Tatsuta; Shigeki Sugawara; Akiyoshi Hara; Masahiro Hosono
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.